|
| 29730433 | The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients. | Clinical Immunology | 2018 |
| 29512145 | Induction and Measurement of Cytotoxic T Lymphocyte Activity. | Current Protocols in Immunology | 2018 |
| 26544708 | Curing HIV/AIDS beyond hematopoietic stem cell transplant. | AIDS | 2015 |
| 24732038 | Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline. | PLoS One | 2014 |
| 24251542 | Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques. | AIDS Research and Human Retroviruses | 2014 |
| 22013040 | Fatal pancreatitis in simian immunodeficiency virus SIV(mac251)-infected macaques treated with 2',3'-dideoxyinosine and stavudine following cytotoxic-T-lymphocyte-associated antigen 4 and indoleamine 2,3-dioxygenase blockade. | Journal of Virology | 2012 |
| 21876718 | Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategy. | F1000 Medicine Reports | 2011 |
| 21931112 | Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis. | Blood | 2011 |
| 20647411 | Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection. | Cancer Epidemiol Biomarkers Prev | 2010 |
| 20887219 | Historical perspective on HIVâ¿exposed seronegative individuals: has nature done the experiment for us? | Journal of Infectious Diseases | 2010 |
| 20001649 | Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus. | Autoimmunity | 2010 |
| 20124101 | TLR activation pathways in HIV-1-exposed seronegative individuals. | Journal of Immunology | 2010 |
| 19895691 | Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo. | AIDS Research and Therapy | 2009 |
| 19093962 | Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? | Journal of Internal Medicine | 2009 |
| 19093956 | Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts. | Journal of Internal Medicine | 2009 |
| 19050384 | HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. | AIDS | 2009 |
| 19131607 | Unsung hero Robert C. Gallo. | Science | 2009 |
| 19299731 | Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques. | Journal of Immunology | 2009 |
| 19334055 | WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication. | Environmental and Molecular Mutagenesis | 2009 |
| 18691036 | Fetal-maternal HLA-A and -B discordance is associated with placental RNase expression and anti-HIV-1 activity. | Current HIV Research | 2008 |
| 19079217 | CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIV(mac251) infection. | Mucosal Immunology | 2008 |
| 17916442 | Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. | Clinical Immunology | 2008 |
| 18390726 | Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. | Journal of Immunology | 2008 |
| 18650129 | PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. | Clinical Immunology | 2008 |
| 18457922 | Differential effect of type I and type II interferons on neopterin production and amino acid metabolism in human astrocyte-derived cells. | Neuroscience Letters | 2008 |
| 18698365 | HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. | PLoS ONE | 2008 |
| 18539209 | The hunt for an HIV vaccine: time to rethink recent failures. | Lancet, The | 2008 |
| 17112786 | HIV-1 immunopathogenesis: how good interferon turns bad. | Clinical Immunology | 2007 |
| 17430110 | How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. | Current Drug Metabolism | 2007 |
| 17158233 | HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. | Blood | 2007 |
| 17678480 | Regulatory T cells (Treg) and HIV/AIDS: summary of the September 7-8, 2006 workshop. | AIDS Research and Human Retroviruses | 2007 |
| 17339444 | Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. | J Immunol | 2007 |
| 17956986 | HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. | Proceedings of the National Academy of Sciences of the United States of America | 2007 |
| 17715231 | Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection. | Journal of Virology | 2007 |
| 18432971 | Induction and measurement of cytotoxic T lymphocyte activity. | Current Protocols in Immunology | 2006 |
| 17078484 | Do regulatory T-cells play a role in AIDS pathogenesis? | AIDS Reviews | 2006 |
| 16632604 | Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. | Proceedings of the National Academy of Sciences of the United States of America | 2006 |
| 16902147 | HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. | Blood | 2006 |
| 16736946 | Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis? | AIDS Reviews | 2006 |
| 16896154 | CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. | Blood | 2006 |
| 16989616 | Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression. | AIDS Research and Human Retroviruses | 2006 |
| 16174727 | Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells. | Proceedings of the National Academy of Sciences of the United States of America | 2005 |
| 15749840 | The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. | Journal of Immunology | 2005 |
| 15585654 | TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. | Blood | 2005 |
| 15466932 | Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. | Blood | 2005 |
| 16046522 | CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. | Blood | 2005 |
| 15207501 | Alloantigen recognition in utero: dual advantage for the fetus? | Trends in Immunology | 2004 |
| 12598767 | Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. | AIDS | 2003 |
| 12468426 | B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. | Blood | 2003 |
| 12814801 | The effect of IL-12 on clinical and laboratory aspects of experimental SLE in young and aging mice. | Experimental Gerontology | 2003 |